Chk shorts are invited to attend, no tickets necessary. BYOB!
Record trx last week. Milligan indicated that the preponderance of hcv 3 and 4 treatments to date require a twelve week regimen
Berstein Conference info:
1.Italy will begin harvoni in June. Spain in q3
2.Sticking to annual margin guidance despite lower first quarter. Conclusion higher margin in future quarters
3. Lower discounts for insurance companies that only authorize hcv 3and 4 treatments. Higher discounts for those that give access to 1 and 2 Conclusion- discounts will be lower given limited access currently to 1 and 2
4 Competition inroad into gild likely to be limited by efficacy, low risk and physician positive experience with Harvoni. Merch drug not as effective on hepc 1a
Growth positive for Hepc drugs globally with activity in large market opportunities of Hep b and Nash
Again Bozo! I don't need to prove anything...I'm content to take out my gains and/or profit just in case NWBO has nothing to offer this weekend just like it did last year! Also, if you read my post I stated I sold some not all! I'm not willing to lose any of my hard earn money....not even a cent! Good luck and I hope you strike rich my friend!!
Analysts for Lloyd's are pretty much divided if this will really benefit Fro in the short term or long term. Not sure how this is going to shake out. Never really know what JF's intentions are.
COOOL!! Should be an interesting next 45 days, once again.
After the upcoming June 17-19, 2015 conference there will be an undoubtedly open, side conversations amongst docs of the trial disclosure shenanigans by Orex management (to pump Contrave). I expect a continued retreat or at best a much flatter growth line for Contrave here in the USA. Those Takeda reps are going to be gun shy of what they can say or not say. Takeda and Orex mgmt are messing with sales rep, street shark heads and doc relationship loyalties.
Focusing back to Belviq - Rx remains generally flat, and poor at this stage (in USA). Good news is ad frequency is back up, Google trend up also, all this despite a #$%$ boring, typical depressed slow-motion DTC content, imho, and of course the worst time slots. But, despite my negativity on the DTC, the increased ad run must have an impact to hold the script count. It was not due to more sales calls.
Funny also that Q was up. They have a captured doc pool that sticks with it.
Strange market. But at these script levels it is really not meaningful quite yet.
Monday is stock SALE DAY by executives, if history is any guide. Between COWEN & SSH Execs ...
Gee, I wonder who pays the rest.
Pioneer Press ^ | 5-28-15 | Fredrick Melo
While Metro Transit's Green Line isn't exactly paying for itself through passenger fares, it's doing a better job than most other Minnesota public transit options. Passengers boarding the state's second light-rail line from its debut in June through the end of 2014 paid $6.21 million into the fare box, or about 35.8 percent of what it costs to operate the 11-mile route. "I think 35 percent is a really good percentage (REALLY)," said St. Paul City Council member Dave Thune. "I love it. I think it has been a success. The kind of traffic it's seeing, going from one end of the city to the other, is excellent -- and it's great for doing something special, like hopping on downtown and going to University Avenue for dinner (at the expense of the taxpayer)."
Pud, it's a DIRECT question..you want to know where the 400ppm is going to go..
I want you to explain where the 5000ppm went..
Stop dodging the DIRECT question..not molten rock, not dinosaurs....where did the 5000ppm CO2 go??
You claim the 400ppm has no where to go, so where did the 5000ppm go??
On Stochastics and MACD oversold. Should bounce nicely higher in the coming week or two as it bottoms out Still in a range of 41-44 though until energy sector resolves itself
Sentiment: Strong Buy
Finally gets an upgrade and this is the stock reaction. Nothing will ever get this moving.
The street has bashed cdti in the previous two articles. Now they say this:
f you take a glance at the chart for Clean Diesel Technologies, you'll see that this stock ripped to the upside on Thursday back above both its 50-day and 200-day moving averages with above-average volume. Volume for the day registered over 464,000 shares, which is above its three-month average of 345,043 shares. This move pushed shares of CDTI back above a major downtrend line that started back in February at around $2.40 a share. This high-volume move over that trend line could be signaling that CDTI is ready to make a large move to the upside.
Interesting that they are the first stock in the article. From what I have been reading, the testing is showing significant improvements in NO reduction and performance. Reading yesterday about the patents something stood out. They apply the new coatings as a overcoat, rather then the standard washcoat. calling this the active phase layer.
BTW this board of munkin's made a big issue when CDTI stated that they had to use some PMG's. Like that was a bad sign. But what is interesting, is that they had patents applied for this exact event, two years in advance. So what they are doing is covering all bases and testing all events. No one can do an end around them. Exactly what I pointed out for the last 9 months. BTW I have this copied and if dbtunr wants to erase by all means.
He has run for the hills like a dog. He posts on IV under different aliases, he has been touting PWE since November, he has caused many to lose their shirts. Rumor is his disappearance is due to some financila advice he gave to an ISIS member to buy PWE